Our experienced small-molecule bioanalytical team can provide development and validation of bioanalytical methods and sample analysis. Our services cover chemically synthesized small molecules, key ingredients of traditional Chinese medicines, endogenous small molecule substances, peptides, ADC payloads, small nucleic acids, etc.

The Platform not only owns experience in analyzing clinical samples of many types of biological drugs, gene and cell therapeutics, but also provides strategies to resolve various target and drug interferences. InnoStar has successfully developed and validated ADA methods for several bi-specific antibody products and executed ADA clinical sample analysis strategies for multi-specific antibodies and cell-based and non-cell-based NAB analysis.

This high-throughput, multi-mode, and high-sensitivity PCR bioanalysis platform supports bioanalysis for gene therapy products, cell therapy products, and RNA vaccines, with services covering oncolytic viruses, CAR-T, stem cells, mRNA vaccines, AAV products, etc. With validated testing methods to measure inflammatory cytokines, TGF-β panel, chemokines, and others, we can minimize testing time and costs for our customers.